Chidozie Ugwumba - Oct 17, 2022 Form 4 Insider Report for BiomX Inc. (PHGE)

Signature
/s/ Chidozie Ugwumba
Stock symbol
PHGE
Transactions as of
Oct 17, 2022
Transactions value $
-$26,599
Form type
4
Date filed
11/14/2022, 05:37 PM
Previous filing
Nov 14, 2022
Next filing
Nov 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHGE Common Stock Sale -$2.71K -8.1K -0.26% $0.34 3.06M Oct 17, 2022 By SymBiosis, LLC F1
transaction PHGE Common Stock Sale -$5.29K -15.3K -0.5% $0.35 3.05M Oct 18, 2022 By SymBiosis, LLC F1
transaction PHGE Common Stock Sale -$1.65K -4.5K -0.15% $0.37 3.04M Oct 19, 2022 By SymBiosis, LLC F1
transaction PHGE Common Stock Sale -$2.48K -6.64K -0.22% $0.37 3.04M Oct 20, 2022 By SymBiosis, LLC F1
transaction PHGE Common Stock Sale -$2K -5.4K -0.18% $0.37 3.03M Oct 21, 2022 By SymBiosis, LLC F1
transaction PHGE Common Stock Sale -$2.06K -5.9K -0.19% $0.35 3.03M Oct 24, 2022 By SymBiosis, LLC F1
transaction PHGE Common Stock Sale -$1.12K -3.07K -0.1% $0.37 3.02M Oct 25, 2022 By SymBiosis, LLC F1
transaction PHGE Common Stock Sale -$4.33K -12.5K -0.41% $0.35 3.01M Oct 26, 2022 By SymBiosis, LLC F1
transaction PHGE Common Stock Sale -$548 -1.51K -0.05% $0.36 3.01M Oct 27, 2022 By SymBiosis, LLC F1
transaction PHGE Common Stock Sale -$543 -1.53K -0.05% $0.36 3.01M Oct 28, 2022 By SymBiosis, LLC F1
transaction PHGE Common Stock Sale -$1.22K -3.3K -0.11% $0.37 3M Oct 31, 2022 By SymBiosis, LLC F1
transaction PHGE Common Stock Sale -$473 -1.3K -0.04% $0.36 3M Nov 1, 2022 By SymBiosis, LLC F1
transaction PHGE Common Stock Sale -$867 -2.42K -0.08% $0.36 3M Nov 2, 2022 By SymBiosis, LLC F1
transaction PHGE Common Stock Sale -$732 -2K -0.07% $0.37 3M Nov 3, 2022 By SymBiosis, LLC F1
transaction PHGE Common Stock Sale -$567 -1.5K -0.05% $0.38 3M Nov 4, 2022 By SymBiosis, LLC F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Chidozie Ugwumba is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The shares are directly held by SymBiosis, LLC.